These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19469259)

  • 21. [Present-day beta-lactame antibiotics in the treatment of urinary infections in pregnant women].
    Rafal'skiĭ VV; Chilova RA; Ostroumova MV
    Urologiia; 2009; (5):14-8. PubMed ID: 20209863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?
    Zahar JR; Lecuit M; Carbonnelle E; Ribadeau-Dumas F; Nassif X; Lortholary O
    Clin Microbiol Infect; 2007 Mar; 13(3):219-21. PubMed ID: 17391375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation].
    Arias CA; Panesso D; Zúñiga M
    Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addressing the challenge of extended-spectrum beta-lactamases.
    Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
    Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor extended-spectrum beta-lactamases.
    Naas T; Poirel L; Nordmann P
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging threat of acquired carbapenemases in Gram-negative bacteria.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2010 Feb; 16(2):99-101. PubMed ID: 20085603
    [No Abstract]   [Full Text] [Related]  

  • 29. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine].
    Cernohorská L; Andrysík T
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):141-6. PubMed ID: 19069027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H; Gustafsson I; Ripa T
    Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract]   [Full Text] [Related]  

  • 32. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.
    Cornaglia G; Akova M; Amicosante G; Cantón R; Cauda R; Docquier JD; Edelstein M; Frère JM; Fuzi M; Galleni M; Giamarellou H; Gniadkowski M; Koncan R; Libisch B; Luzzaro F; Miriagou V; Navarro F; Nordmann P; Pagani L; Peixe L; Poirel L; Souli M; Tacconelli E; Vatopoulos A; Rossolini GM;
    Int J Antimicrob Agents; 2007 Apr; 29(4):380-8. PubMed ID: 17223319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    Bazaz R; Chapman AL; Winstanley TG
    J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi.
    Malhotra VL; Khandpur N; Dass A; Mehta G
    J Commun Dis; 2008 Dec; 40(4):269-72. PubMed ID: 19579719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenemases: a brief review for pediatric infectious disease specialists.
    Overturf GD
    Pediatr Infect Dis J; 2010 Jan; 29(1):68-70. PubMed ID: 20035208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Urinary tract infection in gynecology-obstetrics: resistance to beta-lactam antibiotics and previous antibiotic therapy].
    Borderon E; Tescher M; Du Rouchet E; Lemaire B; Desroche A; Megier P
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):538-42. PubMed ID: 2385451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for bacterial urinary tract infections.
    Wagenlehner FM; Weidner W; Naber KG
    Expert Opin Emerg Drugs; 2005 May; 10(2):275-98. PubMed ID: 15934867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Lactamases of increasing clinical importance.
    Bush K
    Curr Pharm Des; 1999 Nov; 5(11):839-45. PubMed ID: 10539991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New beta-lactamases in enterobacteriaceae. The Danish Society of Clinical Microbiology].
    Hansen DS
    Ugeskr Laeger; 2006 Mar; 168(12):1228. PubMed ID: 16571319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.